Michael A. Metzger, President and COO at Syndax Pharmaceuticals Inc (SNDX), sold 200,000 shares at $20.31 ($4.1M) on 2020-11-04, disclosed to the SEC on 2020-11-06.
Open-market sale of $4.1M SNDX by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.31 | 100,000 | $2.0M | 50.0% |
| 2 | $20.31 | 100,000 | $2.0M | 50.0% |
| Total | $20.31 avg | 200,000 | $4.1M | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |